Skip to content
LexBuild

Medical Devices; Immunology and Microbiology Devices; Classification of Ovarian Adnexal Mass Assessment Score Test System; Correction

---
identifier: "/us/fr/2011-9649"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Medical Devices; Immunology and Microbiology Devices; Classification of Ovarian Adnexal Mass Assessment Score Test System; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2011-9649"
section_name: "Medical Devices; Immunology and Microbiology Devices; Classification of Ovarian Adnexal Mass Assessment Score Test System; Correction"
positive_law: false
currency: "2011-04-21"
last_updated: "2011-04-21"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2011-9649"
document_type: "rule"
publication_date: "2011-04-21"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
cfr_references:
  - "21 CFR Part 866"
fr_citation: "76 FR 22322"
fr_volume: 76
docket_ids:
  - "Docket No. FDA-2010-N-0026"
effective_date: "2011-04-22"
fr_action: "Final rule; correction."
---

#  Medical Devices; Immunology and Microbiology Devices; Classification of Ovarian Adnexal Mass Assessment Score Test System; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Final rule; correction.

**SUMMARY:**

The Food and Drug Administration (FDA) is correcting a final rule that appeared in the *Federal Register* of March 23, 2011 (76 FR 16292). The document announced the classifying of ovarian adnexal mass assessment score test system into class II (special controls). The document was published with an incorrect docket number. This document corrects that error.

**DATES:**

*Effective:* April 22, 2011.

**FOR FURTHER INFORMATION CONTACT:**

Joyce Strong, Office of Policy, Planning and Budget, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3208, Silver Spring, MD 20993-0002, 301-796-9148.

**SUPPLEMENTARY INFORMATION:**

In FR Doc. 2011-6620, appearing on page 16292, in the *Federal Register* of Wednesday, March 23, 2011, the following correction is made:

1. On page 16292, in the first column, in the Docket No. heading, “[Docket No. FDA-2011-N-0026]” is corrected to read “[Docket No. FDA-2010-N-0026].”

Dated: April 13, 2011.

Leslie Kux,

Acting Assistant Commissioner for Policy.